Immune Pharmaceuticals Inc. (Nasdaq: IMNP) named Dr. Daniel Teper to lead the oncology business of its Cytovia subsidiary and to pursue a potential spin-off of Cytovia. The stock price dropped 74 cents to close at $2.79.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|